跳至主要内容
临床试验/EUCTR2007-003187-22-NL
EUCTR2007-003187-22-NL进行中(未招募)1 期

HD 18 for advanced stages: treatment optimization trial in the first line treatment of advanced stage Hodgkin Lymphoma; treatment stratification by means of FDG-PET. - HD 18

VU University Medical Center0 个研究点目标入组 2,101 人开始时间: 2009年6月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
2,101

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Hodgkin Lymfoma
  • - First diagnosis, no previous treatment, histologically proven
  • - Age: 18-60 years
  • - Stage IIB with large mediastinal mass or extranodal lesions, stage III or IV.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - composite lymphoma
  • - previous malignancy
  • - prior chemotherapy or radiation
  • - concurrent disease which precludes protocol treatment
  • - pregnancy, lactation
  • - non-compliance

研究者

发起方
VU University Medical Center

相似试验